DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,399,265 | -64.5% | 2,711,553 | -5.2% | 0.00% | -75.0% |
| Q2 2023 | $18,027,488 | +8.5% | 2,861,506 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $16,616,833 | -39.6% | 2,879,867 | +7.5% | 0.00% | -33.3% |
| Q4 2022 | $27,494,348 | -36.3% | 2,679,761 | +3.8% | 0.01% | -40.0% |
| Q3 2022 | $43,153,000 | +15.1% | 2,580,932 | -3.6% | 0.01% | +11.1% |
| Q2 2022 | $37,490,000 | -8.4% | 2,677,858 | +5.6% | 0.01% | +12.5% |
| Q1 2022 | $40,935,000 | -24.6% | 2,534,702 | 0.0% | 0.01% | -27.3% |
| Q4 2021 | $54,268,000 | +43.6% | 2,534,702 | -1.5% | 0.01% | +37.5% |
| Q3 2021 | $37,791,000 | -24.3% | 2,572,530 | +0.2% | 0.01% | -27.3% |
| Q2 2021 | $49,941,000 | -34.1% | 2,566,148 | +1.2% | 0.01% | -42.1% |
| Q1 2021 | $75,788,000 | – | 2,534,703 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |